Literature DB >> 2952523

N-terminal-methionylated interleukin-1 beta has reduced receptor-binding affinity.

P Wingfield, P Graber, N R Movva, A M Gronenborn, G M Clore, H R MacDonald.   

Abstract

The receptor-binding affinity of recombinant-derived interleukin-1 beta containing unprocessed N-terminal methionine (MAPV-) was 10-fold lower than protein containing the authentic N-terminal sequence (APV-). Structural analysis of the methionylated and non-methionylated proteins by NMR spectroscopy detected no (or minor) conformational differences. The differences in binding affinity, therefore, suggest that the additional N-terminal methionine causes a small, direct or indirect, perturbation of the receptor-binding region.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2952523     DOI: 10.1016/0014-5793(87)80133-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  Isolation and bioactivities of three IL-1 beta N-terminal variants.

Authors:  K A Richard; A W Yem; M R Deibel; N D Staite
Journal:  Agents Actions       Date:  1989-06

2.  Chemical modification of interleukin-1 beta: biochemical characterization of a carbodiimide-catalyzed intramolecular cross-linked protein.

Authors:  A W Yem; D M Guido; W R Mathews; N D Staite; K A Richard; M D Prairie; W C Krueger; D E Epps; M R Deibel
Journal:  J Protein Chem       Date:  1992-12

3.  Three-stage ex vivo expansion of high-ploidy megakaryocytic cells: toward large-scale platelet production.

Authors:  Swapna Panuganti; Alaina C Schlinker; Paul F Lindholm; Eleftherios T Papoutsakis; William M Miller
Journal:  Tissue Eng Part A       Date:  2013-01-14       Impact factor: 3.845

Review 4.  Seamless cloning and gene fusion.

Authors:  Quinn Lu
Journal:  Trends Biotechnol       Date:  2005-04       Impact factor: 19.536

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.